Iovance Biotherapeutics, Inc. (IOVA)
8.17
+0.13
(+1.62%)
USD |
NASDAQ |
Nov 09, 16:00
8.00
-0.17
(-2.08%)
Pre-Market: 08:59
Iovance Biotherapeutics Cash and Short Term Investments (Quarterly) : 376.32M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 376.32M |
| June 30, 2026 | 297.67M |
| March 31, 2026 | 313.44M |
| December 31, 2025 | 296.98M |
| September 30, 2025 | 300.80M |
| June 30, 2025 | 301.18M |
| March 31, 2025 | 360.27M |
| December 31, 2024 | 323.78M |
| September 30, 2024 | 397.49M |
| June 30, 2024 | 412.62M |
| March 31, 2024 | 356.20M |
| December 31, 2023 | 279.87M |
| September 30, 2023 | 361.37M |
| June 30, 2023 | 250.89M |
| March 31, 2023 | 626.29M |
| December 31, 2022 | 471.84M |
| September 30, 2022 | 360.17M |
| June 30, 2022 | 424.46M |
| March 31, 2022 | 482.19M |
| December 31, 2021 | 504.41M |
| September 30, 2021 | 576.45M |
| June 30, 2021 | 656.37M |
| March 31, 2021 | 593.93M |
| December 31, 2020 | 629.44M |
| September 30, 2020 | 714.15M |
| Date | Value |
|---|---|
| June 30, 2020 | 771.88M |
| March 31, 2020 | 245.65M |
| December 31, 2019 | 307.08M |
| September 30, 2019 | 361.87M |
| June 30, 2019 | 404.15M |
| March 31, 2019 | 440.02M |
| December 31, 2018 | 468.52M |
| September 30, 2018 | 260.00M |
| June 30, 2018 | 276.10M |
| March 31, 2018 | 297.08M |
| December 31, 2017 | 145.37M |
| September 30, 2017 | 163.38M |
| June 30, 2017 | 129.02M |
| March 31, 2017 | 147.20M |
| December 31, 2016 | 166.47M |
| September 30, 2016 | 179.28M |
| June 30, 2016 | 191.57M |
| March 31, 2016 | 99.17M |
| December 31, 2015 | 103.70M |
| September 30, 2015 | 110.15M |
| June 30, 2015 | 112.34M |
| March 31, 2015 | 111.28M |
| December 31, 2014 | 44.91M |
| September 30, 2014 | 17.19M |
| June 30, 2014 | 18.44M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AVITA Medical, Inc. | 10.50M |
| Halozyme Therapeutics, Inc. | 1.074B |
| CareDx, Inc. | 250.48M |
| Merck & Co., Inc. | 9.752B |
| SELLAS Life Sciences Group, Inc. | 138.44M |